Table 4.
Comparisons of area under the curves among the radiomic models and Lung-RADS in the primary and validation cohorts.
Pairwise comparison | Primary cohort | Validation cohort | ||
---|---|---|---|---|
Z | P | Z | P | |
Lung-RADS vs. Radiomic signature of low-dose CT | 4.012 | 0.0001* | 2.643 | 0.0082* |
Lung-RADS vs. Radiomic nomogram of low-dose CT | 4.123 | <0.0001* | 2.679 | 0.0074* |
Lung-RADS vs. Radiomic signature of standard-dose CT | 3.329 | 0.0009* | 2.732 | 0.0063* |
Lung-RADS vs. Radiomic nomogram of standard-dose CT | 3.713 | 0.0002* | 2.798 | 0.0051* |
Radiomic signature of low-dose CT vs. Radiomic nomogram of low-dose CT | 0.354 | 0.7236 | <0.001 | 0.999 |
Radiomic signature of low-dose CT vs. Radiomic signature of standard-dose CT | 1.058 | 0.2903 | 0.707 | 0.4794 |
Radiomic signature of low-dose CT vs. Radiomic nomogram of standard-dose CT | 0.385 | 0.7003 | 0.928 | 0.3534 |
Radiomic nomogram of low-dose CT vs. Radiomic signature of standard-dose CT | 1.037 | 0.2998 | 0.599 | 0.5492 |
Radiomic nomogram of low-dose CT vs. Radiomic nomogram of standard-dose CT | 0.663 | 0.5075 | 0.841 | 0.4003 |
Radiomic signature of standard-dose CT vs. Radiomic nomogram of standard-dose CT | 1.019 | 0.3084 | 0.402 | 0.6877 |
*Differences are significant at P < 0.05 corrected with false discovery rate. Lung-RADS, Lung CT Screening Reporting and Data System.